Curaleaf raises Aurora Cannabis bid 25% to US$5.00/share; tender expiry extended to Dec 4, 2026

Curaleaf Holdings, Inc.

Amended consideration is US$1.00 cash (up 33%) plus 0.4013 Curaleaf subordinate voting shares per Aurora share, for total implied value of US$5.00 per share.
Enhanced Offer implies an 86% premium to Aurora's US$2.75 unaffected 30-day VWAP (Aug 10, 2026), or 217% excluding Aurora's cash and ATM issuances.
Maximum consideration cap raised 20% from US$5.00 to US$6.00 per Aurora share, a 118% premium to the unaffected share price.
Combined company: operations in 17 countries, over US$1.5B LTM revenue, ~US$350M LTM Adjusted EBITDA, at least US$40M annual cost synergies and pro forma market cap above US$3B.
CEO Boris Jordan said Curaleaf met much of Aurora's shareholder base but Aurora has refused customary due diligence; Expiry Time moved from Dec 1 to 11:59 p.m. MT on Dec 4, 2026.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.